Zenas BioPharma, Inc. (ZBIO)

NMS – Real Time Price. Currency in USD

31.46

-0.98 (-3.02%)

Market open: Aug 12, 2026, 10:45 AM EDT

32.26

-0.18 (-0.55%)

Previous after-hours: Aug 11, 2026, 7:52 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

10M

50M

Cost of goods sold

-56K

-137K

-113K

-78K

Gross Profit

10M

50M

-78K

Operating expenses (excl. COGS)

-221M

-169M

-77M

-75M

Operating Income

-211M

-164M

-27M

-75M

Non-operating income, total

-166M

-10M

-44M

Pretax income

-378M

-157M

-37M

-119M

Equity in earnings

Taxes

79K

-429K

-301K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-378M

-157M

-37M

-119M

Discontinued operations

Net income

-378M

-157M

-37M

-119M

Dilution adjustment

Preferred dividends

Zenas BioPharma, Inc. (ZBIO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Zenas BioPharma, Inc. (ZBIO)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Zenas BioPharma, Inc. (ZBIO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Zenas BioPharma, Inc. (ZBIO)

Income Statement (Annual)

Income Statement (Annual)